<bill session="110" type="h" number="5629" updated="2021-06-07T20:01:51Z">
  <state datetime="2008-03-13">REFERRED</state>
  <status>
    <introduced datetime="2008-03-13"/>
  </status>
  <introduced datetime="2008-03-13"/>
  <titles>
    <title type="short" as="introduced">Pathway for Biosimilars Act</title>
    <title type="display">Pathway for Biosimilars Act</title>
    <title type="official" as="introduced">To amend the Public Health Service Act to establish a pathway for the licensure of biosimilar biological products, and for other purposes.</title>
  </titles>
  <sponsor bioguide_id="E000215"/>
  <cosponsors>
    <cosponsor bioguide_id="B000213" joined="2008-03-13"/>
    <cosponsor bioguide_id="B000461" joined="2008-04-23"/>
    <cosponsor bioguide_id="B000657" joined="2008-04-08"/>
    <cosponsor bioguide_id="B001227" joined="2008-07-09"/>
    <cosponsor bioguide_id="B001203" joined="2008-03-13"/>
    <cosponsor bioguide_id="C001037" joined="2008-03-13"/>
    <cosponsor bioguide_id="C001065" joined="2008-09-23"/>
    <cosponsor bioguide_id="C001072" joined="2008-05-20"/>
    <cosponsor bioguide_id="D000598" joined="2008-06-17"/>
    <cosponsor bioguide_id="D000210" joined="2008-04-15"/>
    <cosponsor bioguide_id="D000604" joined="2008-09-29"/>
    <cosponsor bioguide_id="D000607" joined="2008-09-17"/>
    <cosponsor bioguide_id="E000289" joined="2008-08-01"/>
    <cosponsor bioguide_id="F000043" joined="2008-09-26"/>
    <cosponsor bioguide_id="F000443" joined="2008-03-13"/>
    <cosponsor bioguide_id="G000549" joined="2008-09-23"/>
    <cosponsor bioguide_id="H000528" joined="2008-07-10"/>
    <cosponsor bioguide_id="H001030" joined="2008-03-13"/>
    <cosponsor bioguide_id="H000712" joined="2008-05-07"/>
    <cosponsor bioguide_id="H001032" joined="2008-09-29"/>
    <cosponsor bioguide_id="H001034" joined="2008-04-29"/>
    <cosponsor bioguide_id="L000397" joined="2008-03-13"/>
    <cosponsor bioguide_id="L000562" joined="2008-03-13"/>
    <cosponsor bioguide_id="M001165" joined="2008-04-08"/>
    <cosponsor bioguide_id="M000312" joined="2008-03-13"/>
    <cosponsor bioguide_id="M001168" joined="2008-05-15"/>
    <cosponsor bioguide_id="M001151" joined="2008-03-13"/>
    <cosponsor bioguide_id="N000015" joined="2008-05-22"/>
    <cosponsor bioguide_id="N000181" joined="2008-04-15"/>
    <cosponsor bioguide_id="P000096" joined="2008-06-26"/>
    <cosponsor bioguide_id="P000587" joined="2008-06-12"/>
    <cosponsor bioguide_id="P000265" joined="2008-07-31"/>
    <cosponsor bioguide_id="P000373" joined="2008-03-13"/>
    <cosponsor bioguide_id="P000523" joined="2008-05-22"/>
    <cosponsor bioguide_id="R000572" joined="2008-03-13"/>
    <cosponsor bioguide_id="S000030" joined="2008-05-08"/>
    <cosponsor bioguide_id="S000364" joined="2008-05-14"/>
    <cosponsor bioguide_id="S001143" joined="2008-06-12"/>
    <cosponsor bioguide_id="S000822" joined="2008-07-29"/>
    <cosponsor bioguide_id="T000460" joined="2008-04-23"/>
    <cosponsor bioguide_id="U000031" joined="2008-03-13"/>
    <cosponsor bioguide_id="W000099" joined="2008-04-30"/>
    <cosponsor bioguide_id="W000784" joined="2008-03-13"/>
  </cosponsors>
  <actions>
    <action datetime="2008-03-13">
      <text>Introduced in House</text>
    </action>
    <action datetime="2008-03-13">
      <text>Sponsor introductory remarks on measure.</text>
      <reference ref="CR E401-402"/>
    </action>
    <action datetime="2008-03-13" state="REFERRED">
      <text>Referred to the Committee on Energy and Commerce, and in addition to the Committee on the Judiciary, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.</text>
    </action>
    <action datetime="2008-03-13">
      <text>Referred to the Committee on Energy and Commerce, and in addition to the Committee on the Judiciary, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.</text>
    </action>
    <action datetime="2008-03-13">
      <text>Referred to the Subcommittee on Health.</text>
    </action>
    <action datetime="2008-04-14">
      <text>Referred to the Subcommittee on Courts, the Internet, and Intellectual Property.</text>
    </action>
  </actions>
  <committees>
    <committee code="HSJU" name="House Judiciary" subcommittee="" activity="Referral"/>
    <committee code="HSJU03" name="House Judiciary" subcommittee="Courts, Intellectual Property, and the Internet" activity="Referral"/>
    <committee code="HSIF" name="House Energy and Commerce" subcommittee="" activity="Referral"/>
    <committee code="HSIF14" name="House Energy and Commerce" subcommittee="Health" activity="Referral"/>
  </committees>
  <relatedbills/>
  <subjects>
    <term name="Health"/>
    <term name="Administrative fees"/>
    <term name="Administrative procedure"/>
    <term name="Administrative remedies"/>
    <term name="Child health"/>
    <term name="Civil actions and liability"/>
    <term name="Clinical trials"/>
    <term name="Confidential communications"/>
    <term name="Department of Health and Human Services"/>
    <term name="Drug approvals"/>
    <term name="Drugs"/>
    <term name="Economics and Public Finance"/>
    <term name="Environmental Protection"/>
    <term name="Families"/>
    <term name="Food and Drug Administration (FDA)"/>
    <term name="Government Operations and Politics"/>
    <term name="Government publicity"/>
    <term name="Intellectual property"/>
    <term name="Law"/>
    <term name="Licenses"/>
    <term name="Medical supplies"/>
    <term name="Patent infringement"/>
    <term name="Patents"/>
    <term name="Pharmaceutical research"/>
    <term name="Poisons"/>
    <term name="Science, Technology, Communications"/>
  </subjects>
  <amendments/>
  <summary date="2008-04-16T20:52:53Z" status="Introduced in House">Pathway for Biosimilars Act - Amends the Public Health Service Act to allow a person to submit an application for licensure of a biological product based on its similarity to a licensed biological product (the reference product).

Requires the Secretary of Health and Human Services to approve the application if: (1) the biological product is biosimilar to the reference product with respect to each condition of use for which the reference product is approved; and (2) the applicant consents to the inspection of the facility that is the subject of the application.

Sets forth requirements for a determination by the Secretary that a biological product is interchangeable with a reference product.

Prohibits a biological product from being evaluated against more than one reference product.

Prohibits licensure under this Act of a biological product containing specified agents or toxins.

Prohibits the Secretary from making approval of an application under this Act effective until 12 yeas after the date on which the reference product was first licensed.

Provides for confidentiality of information received pursuant to this Act.

Sets forth provisions governing patent infringement actions related to this Act.

Deems as patent infringement the submission of a statement under this Act by the applicant setting forth reasons why the making, use, or sale of the biosimilar product would not infringe the patent, or why the patent is invalid or unenforceable, if the purpose of such submission is to obtain approval to engage in the commercial manufacture, use, or sale before the expiration of such patent.</summary>
</bill>
